UNSPSC 51285307: Nitrofurantoin

This classification denotes a urinary anti-infective agent with the molecular formula C8H6N4O5, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 927AH8112L, chemically known as hydantoin, 1-(5-nitro-furfurylideneamino)- but more generally known as nitrofurantoin, which bears U.S. National Institutes of Health Compound Identifier 4509. The European Medicines Agency schedules Nitrofurantoin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09326MIG.

UNSPSC 51285307 Nitrofurantoin, a Commodity code, nominally covers a specific antibiotic pharmaceutical product, but the recent state and local opportunities tagged under this code show limited direct alignment. The Illinois Department of Public Health awarded a $2,999,999.11 pharmaceutical warehouse piggyback contract through the MMCAP Infuse consortium to Chartwell Rx LLC for Doxycycline Hyclate and Ciprofloxacin Hydrochloride — different antibiotics entirely — while Seminole County, Florida released an IFB for Naloxone and drug deactivation systems, which fall outside the antibiotic category altogether. State and local agencies soliciting under this code include state health departments and county health or community services offices pursuing pharmaceutical supply through cooperative purchasing frameworks and competitive bidding. The opportunities reflect a pattern of volume pharmaceutical procurement for public health stockpiles and emergency response, often structured as multi-year contracts with renewal options and managed through established pharmaceutical supply consortia.

Recent activity spans at least two states. Illinois sourced antibiotics through a statewide cooperative vehicle (MMCAP Infuse), while Seminole County, Florida sought public health emergency-response pharmaceuticals on an annual basis with quarterly deliveries. The Seminole County IFB, posted June 30, 2026 with a July 26, 2023 due date, required unit pricing and included potential FEMA funding with associated federal compliance requirements. The Illinois award, completed August 28, 2026, awarded to the lowest responsive and responsible bidder under an IFB process with no set-aside or preference program utilization. The code shows fragmented activity across different drug categories — the nominal nitrofurantoin scope does not dominate recent state and local solicitations. Vendors pursuing this code should monitor cooperative purchasing consortia (MMCAP, similar statewide vehicles) and county-level public health procurement for pharmaceutical supply and emergency-response products, recognizing that recent opportunities diverge from the code's stated product name.